1 x
NAG:
2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.6:
5
residues within 4Å:
Chain A:
N.33,
T.35,
E.37,
D.307,
R.309
No protein-ligand interaction detected (PLIP)
1 x
EPE:
4-(2-HYDROXYETHYL)-1-PIPERAZINE ETHANESULFONIC ACID(Non-functional Binders)
EPE.7:
7
residues within 4Å:
Chain A:
D.13,
Q.17,
D.357,
L.358,
P.359,
R.363
Ligands:
NAG-NAG-BMA-FUC.1
4 PLIP interactions:
4 interactions with chain A
Hydrogen bonds:
A:Q.17,
A:D.357,
A:R.363
Salt bridges:
A:D.357
2 x
3ES:
[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-{[(BENZYLOXY)[(2S)-2-({3-[HYDROXYL(2-PHENYL-(1R)-1-CARBONYL]-AMINO}ETHYL)PHOSPHINYL]-2-[(3-PHENYLISOXAZOL-5-YL)METHYL]-1-OXO-PROPYL}AMINO)-3-(4-HYDROXY-PHENYL)(Non-covalent)
Akif, M. et al., Novel Mechanism of Inhibition of Human Angiotensin-I-Converting Enzyme (Ace) by a Highly Specific Phosphinic Tripeptide. Biochem.J. (2011)